GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Swedencare AB (publ) SECARE.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

19.36

+0.41%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

SEK 2.69bn

FY2016FY2025

Net income

SEK 55.5m

FY2016FY2025

Free cash flow

SEK 275.6m

FY2016FY2025

Shareholders' equity

SEK 6.66bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueSEK 2.69bnSEK 2.54bnSEK 2.34bnSEK 1.83bnSEK 770.4mSEK 239.9mSEK 126.9mSEK 99.1mSEK 85.7mSEK 54.2m
Gross profitSEK 1.52bnSEK 1.46bnSEK 1.29bnSEK 1.02bnSEK 385.9mSEK 157.3mSEK 93.1mSEK 73.5mSEK 63.7mSEK 42.5m
Research and development——SEK 14.6mSEK 12.7mSEK 9.4mSEK 3.9m————
Operating incomeSEK 201.0mSEK 225.0mSEK 174.3mSEK 160.2mSEK 64.6mSEK 60.4mSEK 36.9mSEK 29.4mSEK 16.7mSEK 11.3m
Net incomeSEK 55.5mSEK 98.9mSEK 58.6mSEK 94.5mSEK 54.6mSEK 48.5mSEK 29.9mSEK 23.3mSEK 11.8mSEK 9.8m
Diluted earnings per share0.350.620.370.600.510.560.380.300.150.13

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsSEK 9.51bnSEK 10.32bnSEK 9.52bnSEK 10.00bnSEK 3.47bnSEK 1.15bnSEK 149.4mSEK 117.9mSEK 94.7mSEK 92.8m
Cash and short-term investmentsSEK 103.0mSEK 186.8mSEK 237.3mSEK 245.1mSEK 136.1mSEK 284.1mSEK 45.7mSEK 28.4mSEK 24.1mSEK 20.5m
Total liabilitiesSEK 2.84bnSEK 2.28bnSEK 2.32bnSEK 2.54bnSEK 1.05bnSEK 217.5mSEK 18.1mSEK 19.6mSEK 25.6mSEK 36.1m
DebtSEK 1.80bnSEK 1.47bnSEK 1.66bnSEK 1.90bnSEK 721.5mSEK 178.7mSEK 1.5mSEK 9.3mSEK 17.0mSEK 25.0m
Shareholders' equitySEK 6.66bnSEK 8.03bnSEK 7.21bnSEK 7.46bnSEK 2.42bnSEK 932.9mSEK 131.3mSEK 98.3mSEK 69.0mSEK 56.7m
Shares outstanding160m159m159m159m108m87m79m79m79m77m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsSEK 326.8mSEK 359.1mSEK 444.0mSEK 260.2mSEK 125.8mSEK 36.5mSEK 33.1mSEK 22.0mSEK 12.5mSEK 1.9m
Capital spending−SEK 51.2m−SEK 71.3m−SEK 36.1m−SEK 74.7m−SEK 27.8m−SEK 977,000−SEK 5.1m−SEK 9.4m−SEK 980,000—
Free cash flowSEK 275.6mSEK 287.8mSEK 407.9mSEK 185.5mSEK 98.1mSEK 35.5mSEK 28.0mSEK 12.6mSEK 11.5mSEK 1.9m
Dividends paid−SEK 40.0m−SEK 36.5m−SEK 34.9m−SEK 31.6m−SEK 16.9m−SEK 11.1m−SEK 11.1m−SEK 11.1m−SEK 11.1m—

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueSEK 672.5mSEK 654.7mSEK 684.7mSEK 712.9mSEK 648.8mSEK 645.5mSEK 665.0mSEK 643.6m
Gross profitSEK 411.4mSEK 392.4mSEK 390.2mSEK 48.3mSEK 358.4mSEK 377.0mSEK 387.4mSEK 369.0m
Operating incomeSEK 51.8mSEK 52.4mSEK 27.4mSEK 48.3mSEK 19.2mSEK 45.2mSEK 58.0mSEK 54.4m
Net incomeSEK 23.7mSEK 17.7mSEK 16.4mSEK 22.2m−SEK 6.9mSEK 23.9mSEK 23.8mSEK 24.0m
Diluted earnings per share0.150.110.100.14-0.040.150.150.15
Cash from operationsSEK 78.0mSEK 65.0mSEK 44.0mSEK 152.0mSEK 32.0mSEK 96.0mSEK 81.0mSEK 125.0m
Capital spending−SEK 24.0m−SEK 12.0m−SEK 13.0m−SEK 14.0m−SEK 9.0m−SEK 12.0m−SEK 13.0m−SEK 9.0m
Free cash flowSEK 54.0mSEK 53.0mSEK 31.0mSEK 138.0mSEK 23.0mSEK 84.0mSEK 68.0mSEK 116.0m
Total assetsSEK 9.94bnSEK 9.75bnSEK 9.51bnSEK 9.60bnSEK 9.78bnSEK 9.81bnSEK 10.32bnSEK 9.59bn
Cash and short-term investments—SEK 94.9mSEK 103.0mSEK 145.1mSEK 124.0mSEK 526.9mSEK 186.8mSEK 193.1m
DebtSEK 1.71bnSEK 1.76bnSEK 1.80bnSEK 1.73bnSEK 1.81bnSEK 1.74bnSEK 1.51bnSEK 1.53bn
Shareholders' equitySEK 7.10bnSEK 6.93bnSEK 6.66bnSEK 6.84bnSEK 6.92bnSEK 7.28bnSEK 8.03bnSEK 7.33bn

Financial ratios

Data as of 20 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin56.5%57.5%55.2%55.5%50.1%65.6%
Operating margin5.2%9.2%7.5%6.7%8.6%17.3%
Net margin2.1%3.9%2.5%5.2%7.1%20.2%
Return on equity0.8%1.2%0.8%1.3%2.3%5.2%
Return on assets0.6%1.0%0.6%0.9%1.6%4.2%
Free cash flow yield10.2%11.7%13.0%9.1%6.2%1.9%
Revenue growth6.1%8.6%27.8%137.5%221.1%89.1%
Earnings growth-43.9%68.8%-38.0%73.0%12.6%62.2%
Current ratio2.64x2.95x3.33x3.25x3.94x5.09x
Debt to equity0.27x0.18x0.21x0.23x0.26x0.17x
Equity ratio70.1%77.9%75.7%74.6%69.7%81.1%
Interest coverage1.88x2.84x1.88x3.04x7.32x24.42x
R&D as a share of sales——0.6%0.7%1.2%1.6%
Buybacks as a share of market value-0.6%-0.1%-0.1%-47.3%-23.5%-10.5%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue13.8%62.2%50.2%
Operating income7.9%27.2%32.3%
Net income-16.3%2.7%19.6%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin56.9%56.2%56.0%56.7%
Operating margin8.1%8.1%8.5%9.2%
Net margin2.9%3.3%3.9%4.6%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings110.677.5165.151.6303.2116.748.831.035.339.1
Price to sales2.33.04.12.721.523.611.57.34.97.1

Dividends and splits

Per share, in the currency the company pays

Paid for 6 years. Last went ex-dividend on 24 Apr 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Paid in the year0.280.250.230.220.200.160.14
  • 5-for-1 split · 24 May 2021

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.